Kevin S. Harris
Corporate Officer/Principal at American Society for Virology
Profile
Kevin Harris is Virology Director of Koronis Pharmaceuticals, Inc. and a Member of the American Society for Virology.
Prior to joining Koronis Pharmaceuticals, he was a Senior Molecular Biologist at Abbott Laboratories.
Dr. Harris received a PhD from SUNY Stony Brook in 1994.
Kevin S. Harris active positions
Companies | Position | Start |
---|---|---|
American Society for Virology | Corporate Officer/Principal | 2009-04-16 |
Former positions of Kevin S. Harris
Companies | Position | End |
---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Training of Kevin S. Harris
Stony Brook University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Private companies | 2 |
---|---|
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Health Technology |
American Society for Virology |
- Stock Market
- Insiders
- Kevin S. Harris